Biodel (BIOD), Albireo Enter Merger Agreement

May 25, 2016 7:26 AM

Key Points:Transaction to result in NASDAQ-listed company focused in orphan pediatric liver diseasesAlbireo brings wholly owned, Phase 2 lead asset ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found